Prosight Management, LP

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer % of Class Filed
OnKure Therapeutics, Inc. 13G/A
OKUR · 68277Q105
2.4% 8/10/2026
Event 6/30/2026
MeiraGTx Holdings plc 13G/A
MGTX · G59665102
4.0% 2/13/2026
Event 12/31/2025
Adc Therapeutics SA 13G/A
ADCT · H0036K147
6.8% 2/13/2026
Event 12/31/2025
Janux Therapeutics, Inc. 13G
JANX · 47103J105
5.3% 2/6/2026
Event 2/3/2026
Mural Oncology plc 13G/A
MURA · G63365103
0% 11/13/2025
Event 9/30/2025
Shattuck Labs, Inc. 13G/A
STTK · 82024L103
9.9% 11/13/2025
Event 9/30/2025
Vincerx Pharma, Inc. 13G/A
VINC · 92731L304
4.99% 2/12/2025
Event 12/31/2024